Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: Effects on the degradation of RARα and PML-RARα

Maurizio Gianni', Yesim Kalaç, Isabella Ponzanelli, Alessandro Rambaldi, Mineko Terao, Enrico Garattini

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: Effects on the degradation of RARα and PML-RARα'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds